Skyscape Web Viewer : The Maudsley Deprescribing Guidelines: Antidepressants, Benzodiazepines, Gabapentinoids and Z-drugs : Main Index

View All
About
Addiction antidepressants benzodiazepines and z-drugs gabapentinoids Mis-Diagnosis of Withdrawal Effects As Relapse
Adjunctive medication Other Considerations in Tapering Benzodiazepines and Z-Drugs Other Considerations in Tapering Gabapentinoids Tapering Benzodiazepines and Z-Drugs in Practice Tapering Gabapentinoids in Practice When and Why to Stop Gabapentinoids
Adverse effects antidepressants benzodiazepines and z-drugs gabapentinoids Why Deprescribe?
Agomelatine Agomelatine Factors Influencing Development of Withdrawal Effects Stratfiying Risk of Antidepressant Withdrawal
Akathisia antidepressants benzodiazepines and z-drugs Further Topics Specific Issues in Psychiatric Drug Withdrawal
Alcohol withdrawal antidepressants benzodiazepines and z-drugs gabapentinoids
α-amino-3-hydroxy-5-methyl-4- isoxazolepropionic acid (AMPA)
Alprazolam Alprazolam Switching to Longer-Acting Benzodiazepines to Taper When and Why to Stop Benzodiazepines and Z-Drugs Withdrawal Symptoms During Benzodiazepine Maintenance Treatment
Ambivalence Discussing Deprescribing Antidepressants with Patients Discussing Deprescribing Benzodiazepines and Z-Drugs
American Psychiatric Association (APA) Recent Developments in the Understanding of Antidepressant Withdrawal Tapering Antidepressants Gradually When and Why to Stop Antidepressants Withdrawal Symptoms from Benzodiazepines and Z-Drugs
Amitriptyline Amitriptyline Practical Options in Prescribing Gradually Tapering Doses of Antidepressants
Antidepressants
ANTLER study Discussing Deprescribing Antidepressants with Patients Tapering Antidepressants Gradually When and Why to Stop Antidepressants
Anxiety disorders antidepressants benzodiazepines and z-drugs gabapentinoids,
Anxiolytic effects Hyperbolic Tapering of Benzodiazepines and Z-Drugs Pathophysiology of Benzodiazepine Withdrawal Syndrome When and Why to Stop Benzodiazepines and Z-Drugs Withdrawal Symptoms from Benzodiazepines and Z-Drugs
Barriers to deprescribing Barriers and Facilitators to Deprescribing Tapering Psychiatric Drugs in Practice
Bead counting/weighing Practical Options for Prescribing Gradually Tapering Doses Practical Options in Prescribing Gradually Tapering Doses of Antidepressants
Beneficial effects antidepressants benzodiazepines and z-drugs gabapentinoids Tapering Psychiatric Drugs in Practice Why Deprescribe?
Benzodiazepines
Bipolar disorder Distinguishing Antidepressant Withdrawal Symptoms from New Onset of a Physical or Mental Health Condition Distinguishing Benzodiazepine Withdrawal Symptoms from Return of an Underlying Condition Tapering Benzodiazepines and Z-Drugs in Practice When and Why to Stop Benzodiazepines and Z-Drugs When and Why to Stop Gabapentinoids
Bleeding risks
Boxed warning (black box warn- ing) How to Deprescribe Benzodiazepines and Z-Drugs Safely Protracted Benzodiazepine Withdrawal Syndrome When and Why to Stop Benzodiazepines and Z-Drugs Withdrawal Symptoms from Benzodiazepines and Z-Drugs
British National Formulary (BNF) Other Considerations in Tapering Benzodiazepines and Z-Drugs Other Considerations in Tapering Gabapentinoids Practical Options in Prescribing Gradually Tapering Doses of Antidepressants
Buproprion
Buspirone Buspirone Other Considerations in Tapering Benzodiazepines and Z-Drugs
Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines
Cardiovascular risks Adverse Effects of Antidepressants Clinical Aspects of Antidepressant Withdrawal Discussing Deprescribing Benzodiazepines and Z-Drugs Distinguishing Benzodiazepine Withdrawal Symptoms from Return of an Underlying Condition Overview of Gabapentinoid Withdrawal Effects
Characteristic symptomology Clinical Aspects of Psychiatric Drug Withdrawal Distinguishing Antidepressant Withdrawal Symptoms from Relapse
Chlordiazepoxide Chlordiazepoxide Switching to Longer-Acting Benzodiazepines to Taper